search
Back to results

A Personalized Mind-Body Intervention (MBI) for Improving Sleep Among Women Working in Healthcare

Primary Purpose

Sleep Insufficiency

Status
Recruiting
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Personalized Trial ABCCBA
Personalized Trial CBAABC
Sponsored by
Northwell Health
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Sleep Insufficiency focused on measuring Sleep duration, Sleep quality, Anxiety, Depression

Eligibility Criteria

40 Years - 60 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria: Women (biological sex at birth) Age 40-60 years old Northwell employee/affiliate Self-reported history of short sleep duration (<7h per 24-h period) for at least 3 months After 2-week run-in, Fitbit-verified short sleep duration and ≥80% adherence of Fitbit wear and survey submission Self-report of perceived stress ≥20 using the Perceived Stress Scale (PSS) Access to and capable of using a smartphone Can regularly wear a Fitbit device Exclusion Criteria: Men (biological sex at birth) Age < 40 or >60 years old Women who are pregnant Not a Northwell employee/affiliate No history of short sleep duration or non-adherent to the Fitbit wear and survey submission Self-report of perceived stress <20 using the Perceived Stress Scale (PSS) Does not own or cannot regularly access a smartphone Cannot regularly wear a Fitbit device Unable to complete the study due to cognitive impairment, severe medical or mental illness, or active/prior substance abuse Planned surgeries 6 months from study start date Participants who have been previously told by a doctor to not engage in walking 30 minutes, three times per week or yoga

Sites / Locations

  • Institute of Health System ScienceRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Personalized Trial ABCCBA

Personalized Trial CBAABC

Arm Description

Participants in Arm 1 will receive a Personalized Trial comprised of three components delivered in a ABCCBA sequence over a total period of 12 weeks, where A-mindfulness, B-yoga, and C-guided walking. Participants in this arm will be prompted to complete 3 x 30-minute intervention sessions weekly during applicable treatment weeks. Interventions will be delivered by a virtual link to online videos recorded by an experienced wellness provider. Participants will be limited to three views of the study-provided intervention content each week.

Participants in Arm 2 will receive a Personalized Trial comprised of three components delivered in a CBAABC sequence over a total period of 12 weeks, where A-mindfulness, B-yoga, and C-guided walking. Participants in this arm will be prompted to complete 3 x 30-minute intervention sessions weekly during applicable treatment weeks. Interventions will be delivered by a virtual link to online videos recorded by an experienced wellness provider. Participants will be limited to three views of the study-provided intervention content each week.

Outcomes

Primary Outcome Measures

Mean Within-Subject Difference in Daily Sleep Duration
The effect of the personalized MBI intervention on individual's sleep duration will be assessed in each arm separately. Participants' daily sleep duration will be measured objectively using Fitbit Charge 5 devices and by self-reported questionnaires. Individual changes in the average daily sleep durations between the run-in and each treatment period will be reported using means and 95% confidence intervals (CIs). Bland-Altman plots will be constructed to visualize the agreement between the Fitbit reported and self-reported sleep duration. The effects of treatment on sleep duration will be assessed using generalized estimating equations (GEE) with an unstructured variance-covariance matrix for measures on the same day to that night's sleep. This model accounts for possible autocorrelation and linear trends between sleep duration across time. The GEE models will include time of day of treatment exposure (AM versus PM) as a covariate.

Secondary Outcome Measures

Full Information

First Posted
March 13, 2023
Last Updated
June 29, 2023
Sponsor
Northwell Health
Collaborators
National Institute on Aging (NIA)
search

1. Study Identification

Unique Protocol Identification Number
NCT05789212
Brief Title
A Personalized Mind-Body Intervention (MBI) for Improving Sleep Among Women Working in Healthcare
Official Title
A Personalized (N-of-1) Trial for Testing the Effect of a Mind-Body Intervention (MBI) on Sleep Duration and Quality in Middle-Aged Women Working in Healthcare
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
May 22, 2023 (Actual)
Primary Completion Date
April 1, 2024 (Anticipated)
Study Completion Date
April 1, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Northwell Health
Collaborators
National Institute on Aging (NIA)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The goal of this pilot study is to determine if a personalized trial testing a Mind-Body Intervention (MBI) can produce a meaningful increase in the average daily sleep duration among women 40-60 years of age working in healthcare. A total of 60 eligible participants will be randomized to one of two possible orders of treatment exposure comprised of three components: mindfulness, yoga, and guided walking, each assigned in 2-week block sequences for a total period of 12 weeks. The study will include a 2-week baseline period during which their baseline sleep duration and adherence to the Fitbit wear and survey submission will be assessed. Following the 2-week run-in period, participants deemed eligible and achieved at least 80% adherence of Fitbit wear and survey submission will be randomized to one of the two intervention arms. Exploratory aims include assessments of sleep quality, physiological factors and their direct and indirect relationships with participants' perceived stress, anxiety, and depression.
Detailed Description
The goal of this pilot study is to determine if a personalized trial (N-of-1) employing a Mind-Body Intervention (MBI) can produce a meaningful increase in sleep duration among women 40-60 years of age working at Northwell Health. A total of 60 women with a history of short sleep duration (defined as an average <7h per 24-h period for at least three months) will be enrolled over a period of two years. Participants will complete a 2-week run-in period with no intervention, during which their baseline sleep duration and adherence to the Fitbit wear and survey submission will be assessed. Adherence to Fitbit wear will be defined as recorded activity of greater than 12 hours a day, and recorded sleeping activity greater than 180 minutes in total. Survey adherence will be defined as submission of a given survey. Participants who achieve at least 80% adherence of Fitbit wear and survey submission during baseline period will be randomized to Arm 1 (N=30) or Arm 2 (N=30). Each arm will receive a personalized intervention comprised of three components: mindfulness, yoga and guided walking assigned in 2-week block sequences for a total period of 12 weeks. During each 2-week block, participants will be prompted to complete 3 x 30-minute intervention sessions weekly. Interventions will be delivered by a virtual link to online videos recorded by an experienced wellness provider. Participants will be limited to three views of the study-provided intervention content each week. Changes in average daily sleep duration will be calculated for each participant based on daily measurements between the run-in and each treatment period. The Fitbit devices will also record sleep quality components (sleep onset, sleep staging, and overall sleep score) and physiological factors (breathing/resting heart rate, heart rate variability (HRV) and activity). We will also examine the direct and indirect relationships between perceived stress, anxiety and depression, and sleep quality assessed pre, during (bi-weekly), and post MBI. Enrollment will continue until up to 60 participants have been randomized. Following the intervention, all participants will be assessed over a 2-week follow-up period to allow for a personalized report of their observed data to be generated.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sleep Insufficiency
Keywords
Sleep duration, Sleep quality, Anxiety, Depression

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Phase 2
Interventional Study Model
Crossover Assignment
Model Description
Mixed between and within (Crossover) participant assignment. The study uses a between participant randomization; each of the two arms have a multiple crossover design (with different intervention orders to the crossover).
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Personalized Trial ABCCBA
Arm Type
Experimental
Arm Description
Participants in Arm 1 will receive a Personalized Trial comprised of three components delivered in a ABCCBA sequence over a total period of 12 weeks, where A-mindfulness, B-yoga, and C-guided walking. Participants in this arm will be prompted to complete 3 x 30-minute intervention sessions weekly during applicable treatment weeks. Interventions will be delivered by a virtual link to online videos recorded by an experienced wellness provider. Participants will be limited to three views of the study-provided intervention content each week.
Arm Title
Personalized Trial CBAABC
Arm Type
Experimental
Arm Description
Participants in Arm 2 will receive a Personalized Trial comprised of three components delivered in a CBAABC sequence over a total period of 12 weeks, where A-mindfulness, B-yoga, and C-guided walking. Participants in this arm will be prompted to complete 3 x 30-minute intervention sessions weekly during applicable treatment weeks. Interventions will be delivered by a virtual link to online videos recorded by an experienced wellness provider. Participants will be limited to three views of the study-provided intervention content each week.
Intervention Type
Behavioral
Intervention Name(s)
Personalized Trial ABCCBA
Intervention Description
Participants will receive links for 30-minute videos for all three interventions, for 2 weeks each, 3 times per week, in a specified order (ABCCBA), where A-mindfulness, B-yoga, and C-guided walking.
Intervention Type
Behavioral
Intervention Name(s)
Personalized Trial CBAABC
Intervention Description
Participants will receive links for 30-minute videos for all three interventions, for 2 weeks each, 3 times per week, in a specified order (CBAABC), where A-mindfulness, B-yoga, and C-guided walking.
Primary Outcome Measure Information:
Title
Mean Within-Subject Difference in Daily Sleep Duration
Description
The effect of the personalized MBI intervention on individual's sleep duration will be assessed in each arm separately. Participants' daily sleep duration will be measured objectively using Fitbit Charge 5 devices and by self-reported questionnaires. Individual changes in the average daily sleep durations between the run-in and each treatment period will be reported using means and 95% confidence intervals (CIs). Bland-Altman plots will be constructed to visualize the agreement between the Fitbit reported and self-reported sleep duration. The effects of treatment on sleep duration will be assessed using generalized estimating equations (GEE) with an unstructured variance-covariance matrix for measures on the same day to that night's sleep. This model accounts for possible autocorrelation and linear trends between sleep duration across time. The GEE models will include time of day of treatment exposure (AM versus PM) as a covariate.
Time Frame
13-16 weeks
Other Pre-specified Outcome Measures:
Title
Mean Within-Subject Difference in Daily Sleep Latency
Description
Sleep latency is an important parameter in a sleep study. The duration of time between when the lights are turned off (lights out) as the patient attempts to sleep, until the time patient actually falls asleep will be reported as sleep latency and aggregated daily using Fitbit Charge 5 devices. The effect of the personalized MBI intervention on individual's sleep latency will be assessed in each arm separately. Individual changes in the average daily sleep latency between the run-in and each treatment period will be reported using means (95% CIs) and modeled using Generalized estimating equations (GEE).
Time Frame
13-16 weeks
Title
Mean Within-Subject Difference in Daily Sleep Score
Description
The overall sleep score will be recorded and aggregated daily using Fitbit Charge 5 devices. The effect of the personalized MBI intervention on individual's sleep score will be assessed in each arm separately. Individual changes in the average daily sleep score between the run-in and each treatment period will be reported using means (95% CIs) and modeled using Generalized estimating equations (GEE).
Time Frame
13-16 weeks
Title
Mean Within-Subject Difference in Daily Resting Heart Rate
Description
Fitbit calculates the resting heart rate by measuring the heart rate when it detects sleep, and by measuring it throughout the day while an individual is but inactive (no steps detected). Resting heart rate will be recorded and aggregated daily using Fitbit Charge 5 devices. The effect of the personalized MBI intervention on individual's resting heart rate will be assessed in each arm separately. Individual changes in the average resting heart rate between the run-in and each treatment period will be reported using means (95% CIs) and modeled using Generalized estimating equations (GEE).
Time Frame
13-16 weeks
Title
Mean Within-Subject Difference in Daily Number of Steps
Description
The number of steps per day (physical activity) will be recorded and aggregated daily using Fitbit Charge 5 devices. The effect of the personalized MBI intervention on individual's number of steps per day will be assessed in each arm separately. Individual changes in the daily average number of steps between the run-in and each treatment period will be reported using means (95% CIs) and modeled using Generalized estimating equations (GEE).
Time Frame
13-16 weeks
Title
Mean Within-Subject Difference in Perceived Stress Score
Description
Participant's perceived stress score will be measured using the Ecological Momentary Assessment (EMA) Stress questionnaire on a scale of 0 (low) to 10 (high). EMA will be evaluated pre-intervention (run-in), bi-weekly during the intervention, and post-intervention. Individual changes in the average EMA scores between the run-in and each treatment period will be reported using means (95% CIs).
Time Frame
13-16 weeks
Title
Mean Within-Subject Difference in Anxiety and Depression Scores
Description
Participant's anxiety and depressive disorder scores will be assessed using the Patient Health Questionnaire (PHQ-4), a self-report version of the Primary Care Evaluation of Mental Disorders (PRIME-MD) on a scale of 0 to 3 for a total of four items. Total score will be determined by adding together the scores of each of the 4 items. Scores are rated as normal (0-2), mild (3-5), moderate (6-8), and severe (9-12). Total score ≥3 for first 2 questions suggests anxiety. Total score ≥3 for last 2 questions suggests depression. PHQ-4 will be evaluated pre-intervention (run-in), bi-weekly during the intervention, and post-intervention. Individual changes in the average PHQ-4 scores between the run-in and each treatment period will be reported using means (95% CIs). The role of anxiety and depression as a potential mediator (M) between perceived stress (X) and sleep score (Y), will be determined by mixed effects regression models.
Time Frame
13-16 weeks

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Women (biological sex at birth) Age 40-60 years old Northwell employee/affiliate Self-reported history of short sleep duration (<7h per 24-h period) for at least 3 months After 2-week run-in, Fitbit-verified short sleep duration and ≥80% adherence of Fitbit wear and survey submission Self-report of perceived stress ≥20 using the Perceived Stress Scale (PSS) Access to and capable of using a smartphone Can regularly wear a Fitbit device Exclusion Criteria: Men (biological sex at birth) Age < 40 or >60 years old Women who are pregnant Not a Northwell employee/affiliate No history of short sleep duration or non-adherent to the Fitbit wear and survey submission Self-report of perceived stress <20 using the Perceived Stress Scale (PSS) Does not own or cannot regularly access a smartphone Cannot regularly wear a Fitbit device Unable to complete the study due to cognitive impairment, severe medical or mental illness, or active/prior substance abuse Planned surgeries 6 months from study start date Participants who have been previously told by a doctor to not engage in walking 30 minutes, three times per week or yoga
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Joan Duer-Hefele, RN, MA
Phone
646-766-7153
Email
jduerhefele@northwell.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Karina Davidson, PhD, MASc
Organizational Affiliation
Northwell Health
Official's Role
Principal Investigator
Facility Information:
Facility Name
Institute of Health System Science
City
New York
State/Province
New York
ZIP/Postal Code
10022
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Joan Duer-Hefele, RN, MA
Phone
646-766-7153
Email
jduerhefele@northwell.edu
First Name & Middle Initial & Last Name & Degree
Codruta Chiuzan, PhD

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
All collected individual participant data (IPD) will be de-identified and pooled before sharing on the Open Science Framework, along with a data dictionary.
IPD Sharing Time Frame
The study protocol, including the statistical analysis plan, will be made available in addition to the informed consent form following completion of recruitment but prior to publication of any data from the current study. De-identified, pooled individual participant data will be made available within a year of final participant data collection. We anticipate this data to be available on the Open Science Framework platform indefinitely.
IPD Sharing Access Criteria
All data and supporting information will be stored on the Open Science Framework, a free web application with no access restrictions.

Learn more about this trial

A Personalized Mind-Body Intervention (MBI) for Improving Sleep Among Women Working in Healthcare

We'll reach out to this number within 24 hrs